Bioteque (4107) - Total Liabilities
Based on the latest financial reports, Bioteque (4107) has total liabilities worth NT$1.06 Billion TWD (≈ $33.29 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Bioteque to assess how effectively this company generates cash.
Bioteque - Total Liabilities Trend (2006–2024)
This chart illustrates how Bioteque's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Bioteque to evaluate the company's liquid asset resilience ratio.
Bioteque Competitors by Total Liabilities
The table below lists competitors of Bioteque ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Te Chang Construction Co Ltd
TWO:5511
|
Taiwan | NT$7.01 Billion |
|
Humana AB (publ)
ST:HUM
|
Sweden | Skr6.14 Billion |
|
Aldel Financial II Inc. Class A Ordinary Shares
NASDAQ:ALDF
|
USA | $57.00 |
|
Tiansheng Pharmaceutical Group Co Ltd
SHE:002872
|
China | CN¥679.17 Million |
|
SiS Distribution (Thailand) Public Company Limited
BK:SIS
|
Thailand | ฿7.31 Billion |
|
Chicago Atlantic Real Estate Finance Inc
NASDAQ:REFI
|
USA | $117.16 Million |
|
So-Young International Inc
NASDAQ:SY
|
USA | $852.81 Million |
|
Everspin Technologies Inc
NASDAQ:MRAM
|
USA | $14.45 Million |
Liability Composition Analysis (2006–2024)
This chart breaks down Bioteque's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 4107 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bioteque's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bioteque (2006–2024)
The table below shows the annual total liabilities of Bioteque from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$1.20 Billion ≈ $37.95 Million |
-15.79% |
| 2023-12-31 | NT$1.43 Billion ≈ $45.06 Million |
-1.26% |
| 2022-12-31 | NT$1.45 Billion ≈ $45.64 Million |
+36.95% |
| 2021-12-31 | NT$1.06 Billion ≈ $33.32 Million |
+17.58% |
| 2020-12-31 | NT$899.55 Million ≈ $28.34 Million |
+98.85% |
| 2019-12-31 | NT$452.37 Million ≈ $14.25 Million |
-1.12% |
| 2018-12-31 | NT$457.51 Million ≈ $14.41 Million |
-5.61% |
| 2017-12-31 | NT$484.69 Million ≈ $15.27 Million |
-0.35% |
| 2016-12-31 | NT$486.40 Million ≈ $15.32 Million |
-19.75% |
| 2015-12-31 | NT$606.13 Million ≈ $19.10 Million |
+30.29% |
| 2014-12-31 | NT$465.21 Million ≈ $14.66 Million |
+22.08% |
| 2013-12-31 | NT$381.06 Million ≈ $12.01 Million |
+11.13% |
| 2012-12-31 | NT$342.89 Million ≈ $10.80 Million |
-11.48% |
| 2011-12-31 | NT$387.34 Million ≈ $12.20 Million |
-12.33% |
| 2010-12-31 | NT$441.82 Million ≈ $13.92 Million |
-6.84% |
| 2009-12-31 | NT$474.29 Million ≈ $14.94 Million |
-11.44% |
| 2008-12-31 | NT$535.56 Million ≈ $16.87 Million |
+11.95% |
| 2007-12-31 | NT$478.39 Million ≈ $15.07 Million |
-9.85% |
| 2006-12-31 | NT$530.68 Million ≈ $16.72 Million |
-- |
About Bioteque
Bioteque Corporation manufactures and sells medical device in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage… Read more